Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|November 1, 1995
Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suraminC De Giovanni, C Melani, P Nanni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1994
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cellsM Ferrantini, M Giovarelli, A Modesti, et al.
British Journal of Cancer|August 1, 1985
Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivativesG Nicoletti, P Brambilla, C De Giovanni, et al.
Cancer Research|March 27, 1998
Interleukin 12 gene therapy of MHC-negative murine melanoma metastasesP Nanni, I Rossi, C De Giovanni, et al.
Human Gene Therapy|June 1, 1995
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growthP L Lollini, C De Giovanni, L Landuzzi, et al.
Human Pathology|April 1, 1996
Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumorK Scotlandi, M Serra, M C Manara, et al.
British Journal of Cancer|November 1, 1993
Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cellsD Lauri, C De Giovanni, T Biondelli, et al.
Tumori|August 31, 1989
Giant cell tumor of bone: a model for the in vitro human osteoclast characterizationM Campanacci, G P Bagnara, M Serra, et al.
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
Cancer Research|April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasiaL Cifaldi, E Quaglino, E Di Carlo, et al.
Pageof 11